189 related articles for article (PubMed ID: 24166075)
1. Are race and sex associated with the occurrence of atypical femoral fractures?
Marcano A; Taormina D; Egol KA; Peck V; Tejwani NC
Clin Orthop Relat Res; 2014 Mar; 472(3):1020-7. PubMed ID: 24166075
[TBL] [Abstract][Full Text] [Related]
2. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
Black DM; Geiger EJ; Eastell R; Vittinghoff E; Li BH; Ryan DS; Dell RM; Adams AL
N Engl J Med; 2020 Aug; 383(8):743-753. PubMed ID: 32813950
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-associated femur fractures have high complication rates with operative fixation.
Prasarn ML; Ahn J; Helfet DL; Lane JM; Lorich DG
Clin Orthop Relat Res; 2012 Aug; 470(8):2295-301. PubMed ID: 22669553
[TBL] [Abstract][Full Text] [Related]
4. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
[TBL] [Abstract][Full Text] [Related]
6. Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study.
Kang JS; Won YY; Kim JO; Min BW; Lee KH; Park KK; Song JH; Kim YT; Kim GH
Int Orthop; 2014 Jun; 38(6):1247-53. PubMed ID: 24464018
[TBL] [Abstract][Full Text] [Related]
7. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.
Egol KA; Park JH; Rosenberg ZS; Peck V; Tejwani NC
Clin Orthop Relat Res; 2014 Sep; 472(9):2728-34. PubMed ID: 23604648
[TBL] [Abstract][Full Text] [Related]
8. Bone cross-sectional geometry is not associated with atypical femoral fractures in Asian female chronic bisphosphonate users.
Chou AC; Ng AC; Png MA; Chua DT; Ng DC; Howe TS; Koh JS
Bone; 2015 Oct; 79():170-5. PubMed ID: 26067179
[TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic differences in hip and diaphyseal femur fractures.
Lo JC; Zheng P; Grimsrud CD; Chandra M; Ettinger B; Budayr A; Lau G; Baur MM; Hui RL; Neugebauer R
Osteoporos Int; 2014 Sep; 25(9):2313-8. PubMed ID: 24964891
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates and the risk of atypical femur fractures.
Black DM; Condra K; Adams AL; Eastell R
Bone; 2022 Mar; 156():116297. PubMed ID: 34920168
[TBL] [Abstract][Full Text] [Related]
11. Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy.
Dózsai D; Ecseri T; Csonka I; Gárgyán I; Doró P; Csonka Á
J Orthop Surg Res; 2020 Sep; 15(1):414. PubMed ID: 32933566
[TBL] [Abstract][Full Text] [Related]
12. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
[TBL] [Abstract][Full Text] [Related]
13. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy.
Lo JC; Hui RL; Grimsrud CD; Chandra M; Neugebauer RS; Gonzalez JR; Budayr A; Lau G; Ettinger B
Bone; 2016 Apr; 85():142-7. PubMed ID: 26769007
[TBL] [Abstract][Full Text] [Related]
14. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.
Isaacs JD; Shidiak L; Harris IA; Szomor ZL
Clin Orthop Relat Res; 2010 Dec; 468(12):3384-92. PubMed ID: 20809164
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-related atypical femoral fracture: Managing a rare but serious complication.
Silverman S; Kupperman E; Bukata S
Cleve Clin J Med; 2018 Nov; 85(11):885-893. PubMed ID: 30395525
[TBL] [Abstract][Full Text] [Related]
16. Frequency and associated factor of atypical periprosthetic femoral fracture after hip arthroplasty.
Lee YK; Park CH; Kim KC; Hong SH; Ha YC; Koo KH
Injury; 2018 Dec; 49(12):2264-2268. PubMed ID: 30245278
[TBL] [Abstract][Full Text] [Related]
17. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
[TBL] [Abstract][Full Text] [Related]
18. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.
Lee SH; Lee YH; Suh JS
AJR Am J Roentgenol; 2017 Oct; 209(4):867-873. PubMed ID: 28796551
[TBL] [Abstract][Full Text] [Related]
19. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
[TBL] [Abstract][Full Text] [Related]
20. Burden of bisphosphonate-associated femoral fractures.
Shkolnikova J; Flynn J; Choong P
ANZ J Surg; 2013 Mar; 83(3):175-81. PubMed ID: 23216704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
